Strata Critical Medical (SRTA) Equity Average (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Equity Average data on file, last reported at $282.4 million in Q1 2026.

• Quarterly Equity Average rose 27.88% year-over-year to $282.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $282.4 million (up 27.88% YoY) and the FY2025 annual result came in at $250.5 million, up 9.81% from the prior year.
• Equity Average steadied at $282.4 million in Q1 2026 per SRTA's latest filing, from $281.0 million in the prior quarter.
• Across five years, Equity Average topped out at $287.5 million in Q3 2022 and bottomed at $220.8 million in Q1 2025.
• The 5-year median for Equity Average is $261.8 million (2023), against an average of $257.3 million.
• The widest annual swing landed in 2022, when Equity Average jumped 3137.85%; it then dropped 13.55% in 2024.
• Tracing SRTA's Equity Average over 5 years: stood at $278.6 million in 2022, then retreated by 10.77% to $248.6 million in 2023, then decreased by 8.4% to $227.7 million in 2024, then grew by 23.41% to $281.0 million in 2025, then increased by 0.49% to $282.4 million in 2026.
• Per Business Quant, the three latest SRTA Equity Average figures stand at $282.4 million (Q1 2026), $281.0 million (Q4 2025), and $253.0 million (Q3 2025).

Peer Comparison